Spicing up the fight: Saffron’s powerful impact on prostate cancer revealed

Saffron-treated prostate cancer (PCa) cells.

Why patient centricity is the answer to the clinical trial enrolment gap – Pharmaceutical Technology

Share this article Credit: Shutterstock According to research published by The Economist Intelligence Unit[i], drugs developed using patient-centric designs have a higher chance of launch

February 13, 2024

Opinion | ‘This Was Not a Rare or Exceptional Circumstance’: What We Heard This Week

“It became clear to me that this was not a rare or exceptional circumstance, but that the overwhelming majority of youth receiving this care were

October 28, 2024

Initial high-risk antibody profile for antiphospholipid syndrome tends to remain high in pediatric patients, study finds

A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain

November 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.